title: Gold standard in anticoagulation assessment of left ventricular assist device patients?: how about bronze.
authors.affiliation: Division of Cardiovascular Medicine, University of Utah School of Medicine, Salt Lake City, Utah. Electronic address: josef.stehlik@hsc.utah.edu.
authors.forename: Josef
authors.initials: J
authors.lastname: Stehlik
authors.affiliation: Department of Internal Medicine, Thrombosis Service, University of Utah School of Medicine, Salt Lake City, Utah.
authors.forename: Stacy A
authors.initials: SA
authors.lastname: Johnson
authors.affiliation: Division of Cardiothoracic Surgery, University of Utah School of Medicine, Salt Lake City, Utah.
authors.forename: Craig H
authors.initials: CH
authors.lastname: Selzman
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage*; D065427:Factor Xa Inhibitors / Q000378:metabolism*; D005260:Female; D006333:Heart Failure / Q000628:therapy*; D006353:Heart-Assist Devices / Q000009:adverse effects*; D006493:Heparin / Q000008:administration & dosage*; D006801:Humans; D008297:Male
chemical_list: D000925:Anticoagulants; D065427:Factor Xa Inhibitors; D006493:Heparin
keywords: bleeding; heart failure; heparin; left ventricular assist device; systemic anticoagulation